Skip to main content
. 2021 Jun 21;11(6):916. doi: 10.3390/biom11060916

Table 3.

PDMS microfluidicbrain-on-a-chip platforms.

Organ/Tissue Type Type of Cells Application Reference
Brain organoid-on-a-chip 3D brain organoids derived from human-induced pluripotent stem cells (hiPSCs) Modeling the neurodevelopmental disorders under environmental exposure (e.g., nicotine) [77]
3D brain-on-a-chip Neurospheroids obtained from prenatal E16 rat cortical neurons In vitro brain model for neurodegenerative disease (e.g., Alzheimers’ disease) and high-throughput drug screening [42]
Brain-on-a-chip Neurospheroids obtained from human neural progenitor and human iPSC-derived neural progenitor cells Investigating the development of Alzheimer’s disease and testing drugs against this neuropathology [78]
Neurospheroid network-on-a-chip Neurospheroids obtained from primary culture obtained from the cerebral cortex of Wistar rats Studying neural transplantation therapy for treating severe degenerative brain disease [79]
3D brain-on-a-chip Neurospheroids obtained from prenatal rat (E18) cortical neurons Modulation of cell–ECM interactions at the neuronal level by analyzing neurospheroids and their study in pathological conditions [80]